World experts publish consensus statement on the science of HIV in the context of criminal law
High uptake of HIV testing when self-tests are offered to outpatients in Malawi
Unprecedented hepatitis C infection rates seen in gay men in Amsterdam PrEP programme
Dolutegravir dual therapy works well for first-time HIV treatment
PrEP does not lower feminising hormone level in transgender women
Rapid treatment initiation and less time with detectable HIV linked to falls in new HIV diagnoses in San Francisco and Melbourne
Dolutegravir: update on infant neural tube defects from Botswana
Criminalisation of HIV high on agenda at AIDS 2018
Dolutegravir-based ART recommended for all – if reliable contraception is available
